Home NDC 70518-2406-01 NDC 70518-2406-01 - Lamotrigine This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 70518-2406
Requested NDC 70518-2406-01
Package NDCs from labels 70518-2406-1, 70518-2406-0, 70518-2406-3, 70518-2406-2, 70518-2406-4, 70518-2406-5, 70518-2406-01
Manufacturer REMEDYREPACK INC.
Effective date 2026-07-23
Current FDA listing Not matched in FDA.report NDC product tables DailyMed Labels# Label, Manufacturer, Effective date table Label Manufacturer Effective date Type Lamotrigine - REMEDYREPACK INC. REMEDYREPACK INC. 2026-07-23 HUMAN PRESCRIPTION DRUG LABEL
FDA-Initiated Inactive NDC Indexing# NDC, Effective, Related label table NDC Effective Related label 70518-2406-0 2023-03-09 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-0 2023-03-09 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-0 2023-03-09 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-2 2023-03-09 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-2 2023-03-09 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-2 2023-03-09 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-0 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-0 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-0 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-2 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-2 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994 70518-2406-2 2023-01-30 These highlights do not include all the information needed to use LAMOTRIGINE TABLETS safely and effectively. See full prescribing information for LAMOTRIGINE TABLETS. LAMOTRIGINE Tablets, for oral use Initial U.S. Approval: 1994
DailyMed Package Descriptions# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 70518-2406 LAMOTRIGINE TABLET [REMEDYREPACK INC.] 10 Current NDC, Legacy NDC, 6 package rows 20250316_346f8af3-b850-48e4-bd6e-82ecafca86d2.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 9 of 9 · 167 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lamotrigine LAMOTRIGINE Ascend Laboratories, LLC 70cd448a-2921-4c69-bdf2-5a6ce883bd07 2022-12-09 Boxed warning, Warnings, Adverse reactions Exact identifier rxcui: 282401 rxcui: 198428 rxcui: 198427 rxcui: 198429 unii: U3H27498KS Lamotrigine LAMOTRIGINE ScieGen Pharmaceuticals, Inc. de700ac1-4048-467e-abb1-238953261a97 2022-11-03 Boxed warning, Warnings, Adverse reactions Exact identifier unii: U3H27498KS Lamotrigine LAMOTRIGINE Proficient Rx LP 52273d60-3f27-4846-bf40-014ebcf09417 2022-05-02 Boxed warning, Warnings, Adverse reactions Exact identifier application number: ANDA090170 rxcui: 198427 unii: U3H27498KS Lamotrigine LAMOTRIGINE Proficient Rx LP b94ae2e4-e276-40c1-bc25-da980194fc99 2022-04-01 Boxed warning, Warnings, Adverse reactions Exact identifier application number: ANDA090170 rxcui: 282401 unii: U3H27498KS Lamotrigine LAMOTRIGINE Asclemed USA, Inc. 8ac9dc83-edb2-4ae5-8064-40f113fd3aab 2020-10-14 Boxed warning, Warnings, Adverse reactions Exact identifier application number: ANDA090170 rxcui: 198429 unii: U3H27498KS Lamotrigine LAMOTRIGINE Dr.Reddy's Laboratories Limited e1a0da17-d67c-e44f-bd42-33c4009e4cdd 2018-12-10 Boxed warning, Warnings, Adverse reactions Exact identifier unii: U3H27498KS Lamotrigine LAMOTRIGINE Amneal Pharmaceuticals of New York LLC 380bddae-5b31-4965-96de-97711d859d11 2016-02-02 Boxed warning, Warnings, Adverse reactions Exact identifier unii: U3H27498KS
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.